Royal Papworth Hospital Library

@RoyalPapLib

Supporting Royal Papworth Hospital's excellence in specialist heart and lung patient care, based on research, education and innovation.

Cambridge Biomedical Campus
Vrijeme pridruživanja: lipanj 2011.

Tweetovi

Blokirali ste korisnika/cu @RoyalPapLib

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @RoyalPapLib

  1. Prikvačeni tweet

    We're very excited that our first impact case study has been approved. Congratulations to Becky Scott on her brilliant work.

    Poništi
  2. Great chance to see the inside of the . Book your tour now. Part of Festival 2020

    Poništi
  3. new publication: Familial pulmonary arterial hypertension by KDR heterozygous loss of function. .

    Poništi
  4. new publication: Low Pulmonary Artery Pulsatility Index Is Associated with Adverse Outcomes in Ambulatory Patients with Advanced Heart Failure. . ;

    Poništi
  5. proslijedio/la je Tweet
    4. velj

    Bookings open for the Festival 2020 next week 🧬⚗️ We’re offering the chance to see inside our hospital and meet some of our outstanding teams on one of our tours. 📅 Sunday 22 March ⏰ 11:00-16:00 Full details can be found at

    Poništi
  6. proslijedio/la je Tweet
    31. sij

    Diagnosing lung cancer at an early stage can lead to more treatment options and better outcomes for patients. Read our new report Early Diagnosis Matters here and help us save more lives.

    Poništi
  7. new publication: Long-term outcome of critical aortic valve stenosis. .

    Poništi
  8. new publication: Mechanism of Recurrence of AT: Comparison between First Vs. Redo Procedures in a High-resolution Mapping System. .

    Poništi
  9. new publication: Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma. .

    Poništi
  10. new publication: Maintaining the permanence principle for death during in situ normothermic regional perfusion for donation after circulatory death organ recovery: A United Kingdom and Canadian proposal. . )

    Poništi
  11. new publication: Long-term safety, tolerability and efficacy of macitentan in patients with inoperable chronic thromboembolic pulmonary hypertension: The merit-1 study and its open-label extension merit-2.

    Poništi
  12. new publication: Safety of riociguat for the treatment of pulmonary arterial hypertension: Final data cut from the expert registry. .

    Poništi
  13. new publication: Safety of riociguat for the treatment of chronic thromboembolic pulmonary hypertension: Final data cut from the expert registry. .

    Poništi
  14. World-first surgery . Can you imagine how many hours of research would have gone into it? Remember that Library Services are here to assist with literature searches, journal articles and much more.

    Poništi
  15. new publication: European Association of Cardiothoracic Anesthesiology (EACTA) Cardiothoracic and Vascular Anesthesia Fellowship Curriculum: First Edition. .

    Poništi
  16. new publication: Estrogen imbalance in patients with pulmonary arterial hypertension: Profiling metabolites using LC-MS/MS. .

    Poništi
  17. new publication: Rationale and design of the selexipag in inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (SELECT) trial. .

    Poništi
  18. new publication: Inhaled ciprofloxacin (ARD-3150) in patients with non-cystic fibrosis bronchiectasis and frequent pulmonary exacerbations: A pooled analysis from orbit-3 and orbit-4.

    Poništi
  19. new publication: A multicentre study of anticoagulation in operable chronic thromboembolic pulmonary hypertension. .

    Poništi
  20. proslijedio/la je Tweet
    26. stu 2019.

    Midlands & East. Want to keep up to date with all things AHP related from ? Then please join our AHP network by clicking on this link. Thank you.

    Poništi
  21. proslijedio/la je Tweet

    Thinking of fundraising for us but not sure how you're going to do it? Well now you can take fundraising inspiration from some of our current community and events fundraisers! ⚽️🚲🥳🏃‍♀️ Our fundraisers:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·